SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-003621
Filing Date
2018-03-29
Accepted
2018-03-29 10:53:13
Documents
91
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_immucellcorp.htm 10-K 976529
2 CONSENT OF RSM US LLP f10k2017ex23-1_immucellcorp.htm EX-23.1 2716
3 CERTIFICATION f10k2017ex31_immucellcorp.htm EX-31 9829
4 CERTIFICATION f10k2017ex32_immucellcorp.htm EX-32 6066
  Complete submission text file 0001213900-18-003621.txt   6090353

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE iccc-20171231.xml EX-101.INS 1268436
6 XBRL SCHEMA FILE iccc-20171231.xsd EX-101.SCH 53547
7 XBRL CALCULATION FILE iccc-20171231_cal.xml EX-101.CAL 58686
8 XBRL DEFINITION FILE iccc-20171231_def.xml EX-101.DEF 146451
9 XBRL LABEL FILE iccc-20171231_lab.xml EX-101.LAB 554052
10 XBRL PRESENTATION FILE iccc-20171231_pre.xml EX-101.PRE 366195
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 18721203
SIC: 2835 In Vitro & In Vivo Diagnostic Substances